Atricure to participate in the 2024 leerink partners healthcare crossroads conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming leerink partners healthcare crossroads conference. atricure's management is scheduled to participate in a fireside chat on wednesday, may 29, 2024, at 10:40 a.m. central time. interested parties may acc.
ATRC Ratings Summary
ATRC Quant Ranking